Pages that link to "Q56019470"
Jump to navigation
Jump to search
The following pages link to Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Q56019470):
Displaying 50 items.
- Current imaging strategies for the evaluation of uterine cervical cancer (Q26751279) (← links)
- Clinical practice recommendations for quality of life assessment in patients with gynecological cancer (Q26768706) (← links)
- Role of 18F-FDG PET/CT in the carcinoma of the uterus: a review of literature (Q26851368) (← links)
- New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care (Q28078792) (← links)
- The role of the GP in follow-up cancer care: a systematic literature review (Q30241957) (← links)
- Premenopausal abnormal uterine bleeding and risk of endometrial cancer (Q30244243) (← links)
- The role of surgery in recurrent endometrial cancer (Q30249789) (← links)
- SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis (Q33582882) (← links)
- Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer (Q33648936) (← links)
- A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion (Q33683007) (← links)
- Mistaken identity: endometrial or rectal cancer? (Q33691535) (← links)
- Late metastatic endometrial carcinoma at the repair site of an abdominal wall incisional hernia (Q33735364) (← links)
- Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer (Q33755309) (← links)
- Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB (Q33760587) (← links)
- Effect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status (Q34306540) (← links)
- Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas (Q35121869) (← links)
- Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication (Q35125641) (← links)
- Just how accurate are the major risk stratification systems for early-stage endometrial cancer? (Q35678721) (← links)
- A clinically applicable molecular-based classification for endometrial cancers (Q35863143) (← links)
- Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma (Q35887472) (← links)
- Are preoperative histology and MRI useful for classification of endometrial cancer risk? (Q36080667) (← links)
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up (Q36372293) (← links)
- Immunohistochemical characterisation of molecular subtypes in endometrial cancer (Q36493409) (← links)
- Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway (Q36930125) (← links)
- Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols. (Q37018155) (← links)
- Performance of sentinel lymph node biopsy in high-risk endometrial cancer (Q37086873) (← links)
- Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples. (Q37619708) (← links)
- Recent and current Phase II clinical trials in endometrial cancer: review of the state of art. (Q38203354) (← links)
- Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives (Q38244309) (← links)
- EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects (Q38476060) (← links)
- Ultrasound in gynecological cancer: is it time for re-evaluation of its uses? (Q38484202) (← links)
- Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage? (Q38670354) (← links)
- Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma (Q38670417) (← links)
- Pathophysiology of heavy menstrual bleeding (Q38676700) (← links)
- Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer. (Q38679531) (← links)
- Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis (Q38697895) (← links)
- Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone. (Q38705372) (← links)
- Siegesbeckia orientalis Extract Inhibits TGFβ1-Induced Migration and Invasion of Endometrial Cancer Cells. (Q38751721) (← links)
- Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients (Q38759550) (← links)
- Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers (Q38825241) (← links)
- Endometrial cancer: Not your grandmother's cancer (Q38852405) (← links)
- Role of diffusion-weighted MRI in the differential diagnosis of endometrioid and non-endometrioid cancer of the uterus (Q38963475) (← links)
- The role of fulvestrant in endometrial cancer (Q38970776) (← links)
- Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group (Q39036939) (← links)
- Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group (Q39069570) (← links)
- Endometrial cancer with congenital uterine anomalies: 3 case reports and a literature review (Q39101014) (← links)
- Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma (Q39137327) (← links)
- Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group (Q39204658) (← links)
- Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group (Q39242384) (← links)
- Impact of Radical Hysterectomy on Survival in Patients with Stage 2 Type1 Endometrial Carcinoma: A Matched Cohort Study (Q39629930) (← links)